Goldman Sachs’s Translational Development Acquisition Corp TDAC Stock Holding History

Goldman Sachs’s Portfolio TDAC Stock Details TDAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.66M	Sell	342,787 -42,223	-11%	-$451K	﹤0.01%	4165
2026 Q1	$4.07M	Hold	385,010	–	–	﹤0.01%	3913
2025 Q4	$4.03M	Hold	385,010	–	–	﹤0.01%	3943
2025 Q3	$3.98M	Hold	385,010	–	–	﹤0.01%	3860
2025 Q2	$3.95M	Hold	385,010	–	–	﹤0.01%	3628
2025 Q1	$3.88M	Buy	+385,010	New	+$3.87M	﹤0.01%	3599

Other funds holding TDAC

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Goldman Sachs's TDAC Position: Q2 2026 in Review

Goldman Sachs reduced its Translational Development Acquisition Corp (TDAC) stake by 11% in Q2 2026, selling an estimated $451K and leaving 342,787 shares worth $3.66M. The position accounts for ﹤0.01% of the portfolio, ranked #4165.

Goldman Sachs first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.07M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

Goldman Sachs held 342,787 shares of Translational Development Acquisition Corp worth $3.66M as of Q2 2026.
Goldman Sachs sold 42,223 Translational Development Acquisition Corp shares in Q2 2026, an estimated $451K.
Translational Development Acquisition Corp made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4165 holding.
Goldman Sachs first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
Goldman Sachs's Translational Development Acquisition Corp position peaked at $4.07M in Q1 2026.
35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.